NCT06813235

Brief Summary

The primary objective of this feasibility study is to assess the feasibility and acceptability, and potential clinical significance of an adaptive stepped-care intervention for improving sleep quality among Chinese cancer patients with mild-to-moderate sleep disturbance, using a sequential multiple assessment randomized controlled trial (SMART) design.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
9mo left

Started Feb 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Feb 2025Feb 2027

First Submitted

Initial submission to the registry

January 23, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

February 1, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 6, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 2, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2027

Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

2 years

First QC Date

January 23, 2025

Last Update Submit

March 31, 2025

Conditions

Keywords

Sequential multiple assessment randomized controlled trialsleep disturbancecancer survivorsinsomniaSurvivorship intervention

Outcome Measures

Primary Outcomes (5)

  • Feasibility outcome (1.1)

    Rate of subject recruitment: number of participants consent and being randomized/number of eligible patients x 100

    baseline (T0)

  • Feasibility outcome (1.2)

    Rate of subject retention: number of participants who complete follow-up assessments at 4-month post-intervention (T2) and 10-month post-intervention (T3)/number of participants enrolled x 100

    baseline (T0), 4-month post-intervention (T2) and 10-month post-intervention (T3)

  • Feasibility outcome (1.3)

    Completion/adherence rate to intervention: number of participants who complete the intervention/number of being allocated to attend the intervention x 100

    post-intervention (T1) and 4-month post-intervention (T2)

  • Feasibility outcome (2)

    Intervention satisfaction will be assessed using a tailored questionnaire asking whether different components of the intervention are useful, from a scale of 0-5, 1 being disagree, 5 being completely agree. Participants are also able to comment on whether the intervention's length, duration and frequency of sessions are suitable; as well as provide suggestions for areas for improvement.

    post-intervention (T1; 5 weeks post-baseline) and 4-month post-intervention (T2)

  • Sleep disturbance

    Sleep outcomes will be assessed using the 19-item Pittsburgh Sleep Quality Index (PSQI) evaluating specific features of sleep quality with the global score ranging from 0-21.

    baseline; preintervention (T0), post-intervention (T1; 5 weeks post-baseline), 4-month post-intervention (T2) and 10-month post-intervention (T3).

Secondary Outcomes (2)

  • Hospital Anxiety and Depression Scale (HADS)

    baseline; preintervention (T0), post-intervention (T1; 5 weeks post-baseline), 4-month post-intervention (T2) and 10-month post-intervention (T3).

  • European Organization for Research and Treatment of Cancer (EORTC) quality of life questionnaire (QLQ-C30)

    baseline; preintervention (T0), post-intervention (T1; 5 weeks post-baseline), 4-month post-intervention (T2) and 10-month post-intervention (T3).

Other Outcomes (3)

  • Dysfunctional Beliefs and Attitudes about Sleep (DBAS)

    baseline; preintervention (T0), post-intervention (T1; 5 weeks post-baseline), 4-month post-intervention (T2) and 10-month post-intervention (T3).

  • Global Physical Activity Questionnaire (GPAQ)

    baseline; preintervention (T0), post-intervention (T1; 5 weeks post-baseline), 4-month post-intervention (T2) and 10-month post-intervention (T3).

  • Pre-Sleep Arousal Scale (PSAS)

    baseline; preintervention (T0), post-intervention (T1; 5 weeks post-baseline), 4-month post-intervention (T2) and 10-month post-intervention (T3).

Study Arms (4)

First stage intervention: iDream2Heal

EXPERIMENTAL

iDream2Heal (iD2H) is an unsupervised, self-guided web-based intervention, consisting of five weekly online modules, each containing educational text, illustrative graphics, interactive exercises, and brief videos adapted from cognitive behavioural therapy for insomnia (CBT-I).

Behavioral: iDream2Heal

First stage intervention: Easy Exercise

ACTIVE COMPARATOR

Easy Exercise (eEX) is an unsupervised, self-guided web-based exercise intervention, as an active control. Through five weekly online modules, the key goals of the eEX intervention are to introduce basic sleep hygiene principals, explain the health benefit of exercise in good sleep, introduce varying levels of home-based aerobic exercise and weight training, develop a weekly exercise plan.

Behavioral: Easy Exercise

Second stage intervention: Dream2Heal

EXPERIMENTAL

Dream2Heal (D2H) is a manualised, multi-component intervention which is grounded with core CBT-I elements of stimulus control, sleep restriction, sleep hygiene, relaxation training, and cognitive restructuring. The associations of these components with sleep improvement have been well-established in cancer population. An additional component of symptom management is incorporated, considering its co-occurrence with others physical symptoms. It consists of 5-6 weekly face-to-face sessions (45-60 min each), conducted by a trained counsellor or psychologist.

Behavioral: Dream2Heal

Second stage intervention: iDream2Heal & Easy Exercise

ACTIVE COMPARATOR

The augmented iDream2Heal \& Easy Exercise (iD2H \& eEX) intervention is a combined, unsupervised, self-guided web-based intervention that covers the content of iD2H and eEX interventions. It consists of the addition of an inactive intervention to a partially active intervention.

Behavioral: iDream2Heal & Easy Exercise

Interventions

iDream2HealBEHAVIORAL

iDream2Heal (iD2H) is an unsupervised, self-guided web-based version of the cognitive behavioural therapy for insomnia (CBT-I).

First stage intervention: iDream2Heal
Easy ExerciseBEHAVIORAL

Easy Exercise (eEX) is an unsupervised, self-guided web-based exercise intervention.

First stage intervention: Easy Exercise
Dream2HealBEHAVIORAL

Dream2Heal (D2H) is a manualised, multi-component intervention which is grounded with core CBT-I elements of stimulus control, sleep restriction, sleep hygiene, relaxation training, and cognitive restructuring.

Second stage intervention: Dream2Heal

The augmented iDream2Heal \& Easy Exercise (iD2H \& eEX) intervention is a combined, unsupervised, self-guided web-based intervention that covers the content of iD2H and eEX interventions.

Second stage intervention: iDream2Heal & Easy Exercise

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cantonese- or Mandarin-speaking Chinese patients diagnosed with curable breast, colorectal, or gynaecological cancer
  • Completed treatment (except endocrine therapy) within two years
  • Presenting with Pittsburgh Sleep Quality Index (PSQI) score of 6 to 11 indicating mild-to-moderate sleep disturbance

You may not qualify if:

  • Diagnosis of metastatic cancer
  • Current diagnosis of psychiatric disorder
  • Current diagnosis of another sleep disorder,
  • Have received psychological treatment specifically for sleep disturbance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

QMH department of surgery

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

NeoplasmsParasomniasSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental DisordersSleep Disorders, IntrinsicDyssomnias

Study Officials

  • Wendy Wing Tak Lam, PhD

    School of Public Health, The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Danielle Wing Lam Ng, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The investigator, care provider, investigator and outcomes assessor are masked in terms of not knowing to which condition the participants will be randomized until after the completion of the baseline assessment. The outcomes assessor will break the envelope for the next eligible participant indicating if that participant is to be allocated to intervention or control arms. The participants are masked in terms of not knowing that one intervention is hypothesized to yield larger effects than the other.
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: First stage intervention: Participants will be randomised to either the iD2H (an unsupervised, self-guided web-based version of the D2H intervention based off cognitive behavioural therapy for insomnia (CBT-I)) or eEX intervention (an unsupervised, self-guided web-based exercise intervention), at a 1:1 ratio. Second stage intervention: Non-respondents to the initial intervention will be randomly assigned to either the D2H (face-to-face, therapist led CBT-I intervention) or augmented intervention (combined, unsupervised, self-guided web-based intervention that covers the content of iD2H and eEX interventions) as stepped-up care at a 1:1 ratio. Two sets of block randomisation sequences with randomly permuted block sizes of 2, 4 and 6 will be generated for both stages of the randomisation, where one set will be used for the first stage and the second set will be used for the second stage.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 23, 2025

First Posted

February 6, 2025

Study Start

February 1, 2025

Primary Completion (Estimated)

February 2, 2027

Study Completion (Estimated)

February 2, 2027

Last Updated

April 3, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication will be available from the PI upon reasonable request.

Shared Documents
STUDY PROTOCOL
Time Frame
Starting 6 months after publication
Access Criteria
Information will be available from the PI upon reasonable request. The author to review requests is the PI.

Locations